95 related articles for article (PubMed ID: 11291757)
1. Formation of a defluorinated metabolite of a quinoxaline antiviral drug catalysed by human cytochrome P450 1A2.
Mutch PJ; Dear GJ; Ismail IM
J Pharm Pharmacol; 2001 Mar; 53(3):403-8. PubMed ID: 11291757
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in human hepatocytes: 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carboxylic acid is a major detoxification pathway catalyzed by cytochrome P450 1A2.
Langouët S; Welti DH; Kerriguy N; Fay LB; Huynh-Ba T; Markovic J; Guengerich FP; Guillouzo A; Turesky RJ
Chem Res Toxicol; 2001 Feb; 14(2):211-21. PubMed ID: 11258970
[TBL] [Abstract][Full Text] [Related]
3. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide).
Bournique B; Lambert N; Boukaiba R; Martinet M
Br J Clin Pharmacol; 2001 Jul; 52(1):53-63. PubMed ID: 11453890
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the involvement of human liver microsomes CYP1A2 in the mono-hydroxylation of daidzein.
Peng WX; Wang LS; Li HD; Abd El-Aty AM; Chen GL; Zhou HH
Clin Chim Acta; 2003 Aug; 334(1-2):77-85. PubMed ID: 12867277
[TBL] [Abstract][Full Text] [Related]
5. Urinary metabolites of a novel quinoxaline non-nucleoside reverse transcriptase inhibitor in rabbit, mouse and human: identification of fluorine NIH shift metabolites using NMR and tandem MS.
Dear GJ; Ismail IM; Mutch PJ; Plumb RS; Davies LH; Sweatman BC
Xenobiotica; 2000 Apr; 30(4):407-26. PubMed ID: 10821169
[TBL] [Abstract][Full Text] [Related]
6. Urinary metabolites of a novel quinoxaline non-nucleoside reverse transcriptase inhibitor in dog, cynomolgus monkey and mini-pig.
Ismail IM; Dear GJ; Mutch PJ; Davies LH; Plumb RS; Sweatman BC
Xenobiotica; 1999 Sep; 29(9):957-67. PubMed ID: 10548455
[TBL] [Abstract][Full Text] [Related]
7. CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide.
Bidstrup TB; Bjørnsdottir I; Sidelmann UG; Thomsen MS; Hansen KT
Br J Clin Pharmacol; 2003 Sep; 56(3):305-14. PubMed ID: 12919179
[TBL] [Abstract][Full Text] [Related]
8. Cytochromes P450 1A2 and 3A4 Catalyze the Metabolic Activation of Sunitinib.
Amaya GM; Durandis R; Bourgeois DS; Perkins JA; Abouda AA; Wines KJ; Mohamud M; Starks SA; Daniels RN; Jackson KD
Chem Res Toxicol; 2018 Jul; 31(7):570-584. PubMed ID: 29847931
[TBL] [Abstract][Full Text] [Related]
9. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
[TBL] [Abstract][Full Text] [Related]
10. Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man.
Venkatakrishnan K; von Moltke LL; Duan SX; Fleishaker JC; Shader RI; Greenblatt DJ
J Pharm Pharmacol; 1998 Mar; 50(3):265-74. PubMed ID: 9600717
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
12. Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2.
Turesky RJ; Constable A; Richoz J; Varga N; Markovic J; Martin MV; Guengerich FP
Chem Res Toxicol; 1998 Aug; 11(8):925-36. PubMed ID: 9705755
[TBL] [Abstract][Full Text] [Related]
13. Identification of the human liver cytochrome P450 isoenzymes responsible for the 5-methylhydroxylation of the novel anti-fibrotic drug AKF-PD.
He X; Luo X; Liu Z; Hu G; Cheng Z
Xenobiotica; 2011 Oct; 41(10):844-50. PubMed ID: 21679010
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of heterocyclic aromatic amines by human hepatocytes and cytochrome P4501A2.
Turesky RJ; Guengerich FP; Guillouzo A; Langouët S
Mutat Res; 2002 Sep; 506-507():187-95. PubMed ID: 12351158
[TBL] [Abstract][Full Text] [Related]
15. Application of liquid chromatography/mass spectrometry in accelerating the identification of human liver cytochrome P450 isoforms involved in the metabolism of iloperidone.
Mutlib AE; Klein JT
J Pharmacol Exp Ther; 1998 Sep; 286(3):1285-93. PubMed ID: 9732390
[TBL] [Abstract][Full Text] [Related]
16. Human cytochrome P450 1A2 involvement in the formation of reactive metabolites from a species-specific hepatotoxic pyrazolopyrimidine derivative, 5-n-butyl-7-(3,4,5-trimethoxybenzoylamino)pyrazolo[1,5-a]pyrimidine.
Kuribayashi S; Goto K; Naito S; Kamataki T; Yamazaki H
Chem Res Toxicol; 2009 Feb; 22(2):323-31. PubMed ID: 19138062
[TBL] [Abstract][Full Text] [Related]
17. Brain and CSF entry of the novel non-nucleoside reverse transcriptase inhibitor, GW420867X.
Thomas S; Cass L; Prince W; Segal M
Neuroreport; 2000 Nov; 11(17):3811-5. PubMed ID: 11117496
[TBL] [Abstract][Full Text] [Related]
18. Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
Sadrieh N; Snyderwine EG
Carcinogenesis; 1995 Jul; 16(7):1549-55. PubMed ID: 7614688
[TBL] [Abstract][Full Text] [Related]
19. Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone.
Shou M; Korzekwa KR; Brooks EN; Krausz KW; Gonzalez FJ; Gelboin HV
Carcinogenesis; 1997 Jan; 18(1):207-14. PubMed ID: 9054608
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of sanguinarine in human and in rat: characterization of oxidative metabolites produced by human CYP1A1 and CYP1A2 and rat liver microsomes using liquid chromatography-tandem mass spectrometry.
Deroussent A; Ré M; Hoellinger H; Cresteil T
J Pharm Biomed Anal; 2010 Jul; 52(3):391-7. PubMed ID: 19804952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
